As of 2025-07-12, the Intrinsic Value of Immunic Inc (IMUX) is -5.03 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.83 USD, the upside of Immunic Inc is -705.96%.
Based on its market price of 0.83 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 705.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -5.03 - -5.03 | -5.03 | -705.96% |
P/E | (22.62) - (12.82) | (17.05) | -2154.2% |
DDM - Stable | (6.15) - (25.20) | (15.68) | -1988.8% |
DDM - Multi | (2.01) - (6.87) | (3.16) | -481.1% |
Market Cap (mil) | 79.54 |
Beta | 1.08 |
Outstanding shares (mil) | 95.82 |
Enterprise Value (mil) | 65.24 |
Market risk premium | 4.60% |
Cost of Equity | 11.60% |
Cost of Debt | 5.00% |
WACC | 7.63% |